Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: A meta-analysis
- 1 June 2014
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (9) , 1628-1637
Abstract
No abstract availableKeywords
Funding Information
- Konkuk University
This publication has 27 references indexed in Scilit:
- Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010Journal of Gynecologic Oncology, 2013
- Estrogen replacement therapy after endometrial cancer: a survey of physicians' prescribing practiceClimacteric, 2010
- Managing menopausal symptoms after gynecological cancerCurrent Opinion in Oncology, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Estrogen replacement in surgical stage I and II endometrial cancer survivorsAmerican Journal of Obstetrics and Gynecology, 1996
- Administration of Estrogens to Patients With a Previous Diagnosis of Endometrial AdenocarcinomaSouthern Medical Journal, 1990
- Estrogen replacement therapy following treatment for stage I endometrial carcinomaGynecologic Oncology, 1990
- Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa)Journal of Steroid Biochemistry, 1986